Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | quinisocaine | 21319 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | quinisocaine | 21319 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | quinisocaine | 21319 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | quinisocaine | 21319 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | quinisocaine | 21319 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | quinisocaine | 21319 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | quinisocaine | 21319 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | quinisocaine | 21319 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | quinisocaine | 21319 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | solanine | 439202 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | solanine | 439202 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | solanine | 439202 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | solanine | 439202 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | solanine | 439202 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | solanine | 439202 | drug-path |
Asthma | R-HSA-444620 | map05310 | solanine | 439202 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | solanine | 439202 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | solanine | 439202 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | solanine | 439202 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | solanine | 439202 | drug-path |